<?xml version="1.0" encoding="UTF-8" standalone="yes"?><trialResultsOutput hits="1" offset="0" totalResults="1"><Filters total="48"><Filter label="Trial Technologies" name="trialTechnologies" total="0"/><Filter label="Indications" name="indications" total="1"><FilterOption id="2400" count="1" label="Dyspnea"/></Filter><Filter label="Endpoint Index" name="trialEndpointIndex" total="6"><FilterOption id="4344" count="1" label="Chronic obstructive pulmonary disease - Assessment of Blood Gas Analysis/Alveolar Diffusion Parameters - Assessment of oxygen saturation (SaO2/SpO2)"/><FilterOption id="4432" count="1" label="Chronic obstructive pulmonary disease - Assessment of Dyspnea"/><FilterOption id="4570" count="1" label="Chronic obstructive pulmonary disease - Assessment of Therapy Related Outcomes - Efficacy"/><FilterOption id="4551" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs - Blood pressure assessment"/><FilterOption id="4553" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs - Respiratory rate"/><FilterOption id="4550" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs"/></Filter><Filter label="Trial Drug Phase Highest" name="trialDrugPhaseHighest" total="0"/><Filter label="Trial Company Sponsor" name="trialCompaniesSponsor" total="1"><FilterOption id="1039041" count="1" label="Baqiyatallah University of Medical Sciences"/></Filter><Filter label="Trial Recruitment Status" name="trialRecruitmentStatus" total="1"><FilterOption id="4" count="1" label="Completed"/></Filter><Filter label="Trial Commercially Significant" name="trialIsCommerciallySignificant" total="1"><FilterOption id="NO" count="1" label="No"/></Filter><Filter label="Trial Indications Pioneer" name="trialIndicationsPioneer" total="0"/><Filter label="Registry Id" name="trialRegistries" total="1"><FilterOption id="1000" count="1" label="CT.gov"/></Filter><Filter label="Trial Reason for Discontinuation" name="trialReasonForDiscontinuation" total="0"/><Filter label="Active Controls" name="trialActiveControls" total="0"/><Filter label="Exclusion Criteria Index" name="trialExclusionCriteriaIndex" total="5"><FilterOption id="3239" count="1" label="Chronic obstructive pulmonary disease - Protocol Specified Other Exclusion Criteria"/><FilterOption id="3058" count="1" label="Chronic obstructive pulmonary disease - Subjects co-morbid with Respiratory Diseases/Disorders"/><FilterOption id="3197" count="1" label="Chronic obstructive pulmonary disease - Subjects with Abnormal Laboratory Findings - Subjects with abnormal arterial blood gas analysis"/><FilterOption id="3112" count="1" label="Chronic obstructive pulmonary disease - Subjects with Co-morbid Conditions"/><FilterOption id="6974" count="1" label="Chronic obstructive pulmonary disease - Subjects with History of/Scheduled for Other Treatments"/></Filter><Filter label="Trial Date Enrollment End By Month" name="trialDateEnrollmentEndByMonth" total="0"/><Filter label="Funder Type" name="trialFunderType" total="1"><FilterOption id="ACA" count="1" label="Academic"/></Filter><Filter label="Trial Region" name="trialRegions" total="1"><FilterOption id="MENA" count="1" label="Middle East &amp; North Africa"/></Filter><Filter label="Patient Segment Index" name="trialPatientSegmentIndex" total="1"><FilterOption id="589" count="1" label="Chronic obstructive pulmonary disease - Subjects with Gas Exchange Abnormalities"/></Filter><Filter label="Primary Completion Filter by Month" name="trialPrimaryCompletionDateByMonth" total="0"/><Filter label="Trial Country" name="trialCountries" total="1"><FilterOption id="IR" count="1" label="Iran"/></Filter><Filter label="Trial Patient Selection" name="trialTermsPatientSelection" total="3"><FilterOption id="EGMAL" count="1" label="Male"/><FilterOption id="EAMAA" count="1" label="Middle-aged Adults (45-64 yrs)"/><FilterOption id="EAYAD" count="1" label="Young Adults (18-44 yrs)"/></Filter><Filter label="Trial Terms Design" name="trialTermsDesign" total="5"><FilterOption id="SISXOV" count="1" label="Crossover Assignment"/><FilterOption id="SSTINV" count="1" label="Interventional"/><FilterOption id="SIMMBD" count="1" label="Multiple Blind"/><FilterOption id="SIARND" count="1" label="Randomized"/><FilterOption id="SIPTRE" count="1" label="Treatment"/></Filter><Filter label="Trial Source" name="trialSources" total="1"><FilterOption id="CTGOV" count="1" label="ClinicalTrials.gov only"/></Filter><Filter label="Trial Actions Secondary Interventions Primary" name="trialActionsSecondaryInterventionsPrimary" total="0"/><Filter label="Trial Endpoint Achieved" name="trialEndpointsAchieved" total="0"/><Filter label="Endpoint Index Secondary" name="trialEndpointIndexSecondary" total="0"/><Filter label="Biomarker" name="trialBiomarkerNames" total="0"/><Filter label="Trial Terms Endpoint" name="trialTermsEndpoint" total="2"><FilterOption id="SIEEFC" count="1" label="Efficacy"/><FilterOption id="SIESFT" count="1" label="Safety"/></Filter><Filter label="Trial Interventions Primary In Regimen Name Display" name="trialInterventionsPrimaryInRegimenNameDisplay" total="0"/><Filter label="Trial Document Source" name="trialDocumentSource" total="0"/><Filter label="Trial Interventions Primary Alone Name Display" name="trialInterventionsPrimaryAloneNameDisplay" total="0"/><Filter label="Trial Interventions Control In Regimen Name Display" name="trialInterventionsControlInRegimenNameDisplay" total="0"/><Filter label="Trial Category" name="trialCategory" total="2"><FilterOption id="9" count="1" label="Medical procedure"/><FilterOption id="4" count="1" label="Small molecule"/></Filter><Filter label="Trial Outcome Available" name="trialOutcomesAvailable" total="1"><FilterOption id="NO" count="1" label="No"/></Filter><Filter label="Trial Actions Primary Interventions Primary" name="trialActionsPrimaryInterventionsPrimary" total="0"/><Filter label="Trial Company Collaborator" name="trialCompaniesCollaborator" total="0"/><Filter label="Trial Actions Secondary Interventions Control" name="trialActionsSecondaryInterventionsControl" total="0"/><Filter label="Biomarker Type" name="trialBiomarkerTypes" total="0"/><Filter label="Biomarker Role" name="trialBiomarkerRoles" total="0"/><Filter label="Interventions" name="trialInterventions" total="0"/><Filter label="Endpoint Index Primary" name="trialEndpointIndexPrimary" total="6"><FilterOption id="4344" count="1" label="Chronic obstructive pulmonary disease - Assessment of Blood Gas Analysis/Alveolar Diffusion Parameters - Assessment of oxygen saturation (SaO2/SpO2)"/><FilterOption id="4432" count="1" label="Chronic obstructive pulmonary disease - Assessment of Dyspnea"/><FilterOption id="4570" count="1" label="Chronic obstructive pulmonary disease - Assessment of Therapy Related Outcomes - Efficacy"/><FilterOption id="4551" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs - Blood pressure assessment"/><FilterOption id="4553" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs - Respiratory rate"/><FilterOption id="4550" count="1" label="Chronic obstructive pulmonary disease - Assessment of Vital Signs"/></Filter><Filter label="Sponsors/Collaborators" name="trialCompanies" total="1"><FilterOption id="1039041" count="1" label="Baqiyatallah University of Medical Sciences"/></Filter><Filter label="Last Changed Date By Day" name="trialDateChangeLastByDay" total="1"><FilterOption count="1" label="2018-01-16"/></Filter><Filter label="Trial Date End By Month" name="trialDateEndByMonth" total="0"/><Filter label="Trial Date Start By Month" name="trialDateStartByMonth" total="1"><FilterOption count="1" label="200704"/></Filter><Filter label="Trial Phase" name="trialPhase" total="1"><FilterOption id="C23" count="1" label="Phase 2/Phase 3 Clinical"/></Filter><Filter label="Inclusion Criteria Index" name="trialInclusionCriteriaIndex" total="5"><FilterOption id="2083" count="1" label="Chronic obstructive pulmonary disease - Subjects with Abnormal Arterial Gas Analysis"/><FilterOption id="2155" count="1" label="Chronic obstructive pulmonary disease - Subjects with Abnormal Laboratory Parameters"/><FilterOption id="2212" count="1" label="Chronic obstructive pulmonary disease - Subjects with Abnormal Physical/Systemic Assessment - Subjects with increased respiratory rate"/><FilterOption id="2072" count="1" label="Chronic obstructive pulmonary disease - Subjects with Breathlessness"/><FilterOption id="2106" count="1" label="Chronic obstructive pulmonary disease - Subjects with History of/Scheduled to Receive Therapy"/></Filter><Filter label="Trial Interventions Control Alone Name Display" name="trialInterventionsControlAloneNameDisplay" total="0"/><Filter label="Trial Actions Primary Interventions Control" name="trialActionsPrimaryInterventionsControl" total="0"/><Filter label="Trial Indications Adverse" name="trialIndicationsAdverse" total="0"/></Filters><SearchResults><Trial Id="169834"><Indications><Indication>Dyspnea</Indication></Indications><CompaniesSponsor><Company>Baqiyatallah University of Medical Sciences</Company></CompaniesSponsor><Countries><Country>Iran</Country></Countries><DateChangeLast>2018-01-16T00:00:00Z</DateChangeLast><DateStart>2007-04-30T00:00:00Z</DateStart><Identifiers><Identifier>B12406</Identifier><Identifier>NCT00642447</Identifier></Identifiers><InterventionsPrimaryDisplay><Intervention>heliox alone</Intervention></InterventionsPrimaryDisplay><PatientCountEnrollment>23</PatientCountEnrollment><Phase>Phase 2/Phase 3 Clinical</Phase><RecruitmentStatus>Completed</RecruitmentStatus><Teaser>The purpose of this study was to assess the effect of heliox with noninvasive positive pressure ventilation to decrease dyspnea and improve physiological and respiratory measures in patients with a previous exposure to sulfur mustard gas.</Teaser><TrialCategories><Category>Medical procedure</Category><Category>Small molecule</Category></TrialCategories><TermsDesign><Term>Interventional</Term><Term>Treatment</Term><Term>Randomized</Term><Term>Multiple Blind</Term><Term>Crossover Assignment</Term></TermsDesign><TermsEndpoint><Term>Safety</Term><Term>Efficacy</Term></TermsEndpoint><EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Blood Gas Analysis/Alveolar Diffusion Parameters - Assessment of oxygen saturation (SaO2/SpO2)</EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Dyspnea</EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Therapy Related Outcomes - Efficacy</EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Vital Signs</EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Vital Signs - Blood pressure assessment</EndpointIndex><EndpointIndex>Chronic obstructive pulmonary disease - Assessment of Vital Signs - Respiratory rate</EndpointIndex></EndpointIndex><TermsPatientSelection><Term>Male</Term><Term>Young Adults (18-44 yrs)</Term><Term>Middle-aged Adults (45-64 yrs)</Term></TermsPatientSelection><TitleDisplay>Helium : Oxygen Noninvasive Positive Pressure Ventilation in Patients Exposed to Sulfur Mustard</TitleDisplay><PatientSegmentTerms><PatientSegment>Chronic obstructive pulmonary disease - Subjects with Gas Exchange Abnormalities</PatientSegment></PatientSegmentTerms><PrimaryCompletionDate/><NumberOfSites>1</NumberOfSites></Trial></SearchResults></trialResultsOutput>